English
English Chinese Simplified Chinese Traditional French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
🇲🇽 Project Update | Querétaro, Mexico 🇲🇽
Marketing Campaign
News Categories
Featured News
LBT LB-20 Medical Cyclotron Supports Clinical PET Imaging and Radiopharmaceutical Research in Xi’an, China
LBT LB-20 Medical Cyclotron Supports ...
What Makes RDC Development So Challenging? From Molecular Design to Cyclotron Radionuclide Production
What Makes RDC Development So Challen...
Expanding PET Radiopharmaceutical Production in Burkina Faso with an LBT 11 MeV Medical Cyclotron
Expanding PET Radiopharmaceutical Pro...
RDC vs ADC: What Makes Radionuclides a Unique Therapeutic Payload? 🎯 ADC and RDC share a similar idea: use a targeting molecule to find the tumor, then let the payload do the killing. But their thera
RDC vs ADC: What Makes Radionuclides ...
Beyond ¹⁷⁷Lu and ²²⁵Ac: Where Are Next-Generation Therapeutic Radionuclides Heading?
Beyond ¹⁷⁷Lu and ²²⁵Ac: Where Are Nex...
β vs α: Why Are There Two Different Routes in Radionuclide Therapy?
β vs α: Why Are There Two Different R...
Why Do Diagnostic and Therapeutic Radionuclides Need to Be Matched?
Why Do Diagnostic and Therapeutic Rad...
From Imaging to Therapy: How Radioactive Decay Shapes Clinical Use
From Imaging to Therapy: How Radioact...
From Seeing Disease to Treating It: Why Radiopharmaceuticals Matter
From Seeing Disease to Treating It: W...
🧪 When a Pharmaceutical Company Builds Its Own Radionuclide Production Capability
🧪 When a Pharmaceutical Company Build...
0102030405

🇲🇽 Project Update | Querétaro, Mexico 🇲🇽

2026-07-22
Construction continues to make steady progress on an LBT LB-11MTS 11Mev medical cyclotron project in Querétaro, Mexico.
🏗️ The cyclotron bunker is taking shape, with reinforced concrete structures and radiation shielding works progressing according to plan.
🧱 Construction of the radiopharmaceutical production area and supporting infrastructure is also moving forward in parallel, preparing the site for equipment installation.
⚙️ Once the civil works are completed, the project will move into the next phase, including cyclotron installation, system integration, and commissioning.
Designed around the LBT LB-11MTS, this project will provide a complete PET radiopharmaceutical production platform to support the continued development of nuclear medicine in the region.
We look forward to sharing more updates as the project progresses.